CAUTI treatment market seen reaching $1.67 billion by 2030

By AI, Created 4:33 PM UTC, May 18, 2026, /AGP/ – The Business Research Company says the catheter-associated urinary tract infections treatment market will grow from $1.26 billion in 2025 to $1.67 billion by 2030, driven by hospital-acquired infections, an aging population and broader adoption of preventive care. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - Catheter-associated urinary tract infections, or CAUTIs, remain a major source of hospital-acquired infections. - The market outlook points to steady demand for treatments tied to infection control, patient safety and care for older adults. - Growth in this segment also reflects broader pressure on healthcare systems to reduce complications linked to indwelling catheters.

What happened: - The Business Research Company projected the CAUTI treatment market will rise from $1.26 billion in 2025 to $1.33 billion in 2026. - The firm forecast the market will reach $1.67 billion by 2030. - The projection implies a 5.7% compound annual growth rate in the historical period and a 5.9% CAGR through 2030. - The report was released from London on May 14, 2026. - The company made the report available through a free sample request and a full market report.

The details: - CAUTI treatment includes catheter removal or replacement when possible, antimicrobial therapy based on clinical evaluation and urine culture results, and supportive care. - The report cites rising CAUTI prevalence, higher patient volumes in hospitals and clinics, widespread antibiotic use, expanding healthcare infrastructure and stronger infection-prevention awareness as near-term growth drivers. - The forecast also points to growing use of urinary catheter coatings, probiotics, immunotherapy, personalized treatment plans, online drug delivery, telehealth and preventive care. - The market is expanding alongside broader hospital-acquired infection rates. - CIDRAP reported in May 2024 that nearly 4.3 million patients contracted at least one healthcare-acquired infection annually in hospitals across the European Union and European Economic Area during 2022 and 2023. - The report says the expanding elderly population is also fueling demand for CAUTI treatment. - UK Parliament’s House of Commons Library said the UK had 12.7 million people aged 65 or older in 2022, equal to 19% of the population. - The same data projected that number will reach 22.1 million by 2072, or 27% of the population. - North America held the largest share of the market in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - The forecast suggests CAUTI treatment is moving from a routine clinical need to a market shaped by prevention, personalization and digital care access. - The focus on catheter coatings and telehealth points to demand for solutions that reduce infection risk before treatment is needed. - The aging population trend adds a long-duration tailwind because older patients are more likely to need catheter-related care.

What’s next: - Healthcare providers are likely to keep emphasizing prevention, early intervention and catheter management as infection-control priorities. - Market growth will depend on how quickly new treatment approaches, remote care channels and coating technologies gain adoption. - Regional momentum may shift further toward Asia-Pacific if healthcare capacity and access continue to expand there.

The bottom line: - CAUTI treatment is a growing niche inside infection care, with demand supported by hospital-acquired infection pressure, aging demographics and new treatment approaches.